News
MicroRNA-33a and microRNA-33b are encoded within the mammalian SREBF1 and SRBF2 genes, respectively, and both SREBF1 and ...
Researchers identified a combination of two existing cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s ...
Small molecule drugs are low-molecular-weight, organic compounds used to treat a wide range of conditions. Here's what you should know.
Colon cancer is often driven by cancer stem cells, which resist treatment and lead to relapse. In a recent study, researchers ...
In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...
Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...
Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.
From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ ...
Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease ...
PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced the publication of a ...
19h
The Brighterside of News on MSNTwo FDA-approved cancer drugs significantly reverse Alzheimer's diseaseAlzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results